N

New Phase Research & Development | Knoxville, TN

Research site

(Unclaimed)

Location

6914 Office Park Circle, Knoxville, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Ranolazine

LY3298176

Tirzepatide

Testosterone

Metformin

Bococizumab

MD-7246

Capsaicin

Loperamide

RPL554

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 38 total trials

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus (GALACELA)

A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily fo...

Active, not recruiting

Systemic Lupus Erythematosus

Drug: GLPG3667

Drug: Placebo

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Obicetrapib

Drug: Placebo

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and sa...

Active, not recruiting

Post Surgical Neuropathic Pain

Drug: Qutenza (capsaicin) 8% topical system

Drug: capsaicin 0.04% topical system